14 Results

People

  1. Zelefsky
    Zelefsky
  2. Coleman
    Coleman
  3. Hakimi
    Hakimi
  4. Russo
    Russo
  5. Benfante
    Benfante
  6. Khaleel
    Khaleel
  7. Ostrovnaya
    Ostrovnaya
  8. Akin
    Akin
  9. Arroyave Villada
    Arroyave Villada
  10. Becerra
    Becerra

Groups

  1. Survivorship Research (14)
  2. Radiation Oncology, Department of (10)
  3. Surgery (4)
  4. Urology (4)
  5. Biostatistics Service (2)
  6. Epidemiology and Biostatistics (2)
  7. GME, Urology (2)
  8. Graduate Medical Education (2)
  9. Sloan Kettering Institute Postdocs (2)
  10. Advanced Practice Providers (1)
  1. "controlled study"
  2. "Survivorship Research"
  3. "Urologic Oncology
Formats
  1. Journal Article (14)
Groups
  1. Survivorship Research (14)
  2. Radiation Oncology, Department of (10)
  3. Surgery (4)
  4. Urology (4)
  5. Biostatistics Service (2)
  6. Epidemiology and Biostatistics (2)

More Groups

People
  1. Michael Zelefsky (10)
  2. Jonathan Coleman (4)
  3. Abraham Hakimi (3)
  4. Paul Russo (3)
  5. Irina Ostrovnaya (2)
  6. Nicole Benfante (2)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2020 (1)
  4. 2015 (1)
  5. 2006 (4)
  6. 2005 (6)
Publications
  1. Urologic Oncology: Seminars and Original Investigations (14)
Publishers
  1. Elsevier Inc. (14)

Results (14)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Surgical outcomes of cytoreductive nephrectomy in patients receiving systemic immunotherapy for advanced renal cell carcinoma
    Journal Article

    Reese, S. W.; Eismann, L.; White, C.; Arroyave Villada, J.; Khaleel, S.; Ostrovnaya, I.; Vazquez-Rivera, K.; Carlo, M. I.; Feldman, D.; Lee, C. H.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • Adverse pathologic features impact survival outcomes for small renal masses following nephrectomy
    Journal Article

    Khaleel, S.; Truong, H.; Jiang, S.; K-Lee, P.; Davelman, B.; Gordon, D.; Benfante, N.; Arora, A.; Ostrovnaya, I.; Tickoo, S.; more...
    Urologic Oncology: Seminars and Original Investigations (2023)

    Fulltext@MSK | Save
  • Preoperative nomogram predicting 12-year probability of metastatic renal cancer – Evaluation in a contemporary cohort
    Journal Article

    Mano, R.; Duzgol, C.; Ganat, M.; Goldman, D. A.; Blum, K. A.; Silagy, A. W.; Walasek, A.; Sanchez, A.; DiNatale, R. G.; Marcon, J.; more...
    Urologic Oncology: Seminars and Original Investigations (2020)

    Fulltext@MSK | Save
  • Salvage ablative therapy in prostate cancer: International multidisciplinary consensus on trial design
    Journal Article

    Van Den Bos, W.; Muller, B. G.; de Bruin, D. M.; de Castro Abreu, A. L.; Chaussy, C.; Coleman, J. A.; Finelli, A.; Gill, I. S.; Gross, M. E.; Jenniskens, S. F. M.; more...
    Urologic Oncology: Seminars and Original Investigations (2015)

    Fulltext@MSK | Save
  • Psychological functioning associated with prostate cancer: Cross-sectional comparison of patients treated with radiotherapy, brachytherapy, or surgery. Hervouet S, Savard J, Simard S, Ivers H, Laverdière J, Vigneault E, Fradet Y, Lacombe L, School of Psychology, Laval University, Québec, Canada
    Journal Article

    Zelefsky, M. J.
    Urologic Oncology: Seminars and Original Investigations (2006)

    Fulltext@MSK | Save
  • Postoperative radiotherapy after radical prostatectomy: A randomised controlled trial (EORTC trial 22911). Bolla M, van Poppel H, Collette L, van Cangh P, Vekemans K, Da Pozzo L, de Reijke TM, Verbaeys A, Bosset J-F, van Velthoven R, Maréchal J-M, Scalliet P, Haustermans K, Piérart M, European Organization for Research and Treatment of Cancer, Department of Radiation Oncology, Centre Hospitalier Universitaire A Michallon, Grenoble, France
    Journal Article

    Zelefsky, M. J.
    Urologic Oncology: Seminars and Original Investigations (2006)

    Fulltext@MSK | Save
  • Risk-adapted androgen deprivation and escalated three-dimensional conformal radiotherapy for prostate cancer: Does radiation dose influence outcome of patients treated with adjuvant androgen deprivation? A GICOR study. Zapatero A, Valcárcel F, Calvo FA, Algás R, Béjar A, Maldonado J, Villá S, Department of Radiation Oncology, Hospital Universitario de la Princesa, Madrid, Spain
    Journal Article

    Zelefsky, M. J.
    Urologic Oncology: Seminars and Original Investigations (2006)

    Fulltext@MSK | Save
  • Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: Results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial. Denham JW, Steigler A, Lamb DS, Joseph D, Mameghan H, Turner S, Matthews J, Franklin I, Atkinson C, North J, Poulsen M, Christie D, Spry NA, Tai K-H, Wynne C, Duchesne G, Kovacev O, D'Este C, Trans-Tasman Radiation Oncology Group, Newcastle Mater Hospital, Newcastle, New South Wales, Australia
    Journal Article

    Zelefsky, M. J.
    Urologic Oncology: Seminars and Original Investigations (2006)

    Fulltext@MSK | Save
  • Radiation dose delivered to the proximal penis as a predictor of the risk of erectile dysfunction after three-dimensional conformal radiotherapy for localized prostate cancer: Wernicke AG, Valicenti R, Dieva K, Houser C, Pequignot E, Department of Radiation Oncology, Jefferson Medical College and Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA
    Journal Article

    Zelefsky, M.
    Urologic Oncology: Seminars and Original Investigations (2005)

    Fulltext@MSK | Save
  • Vessel-sparing prostate radiotherapy: Dose limitation to critical erectile vascular structures (internal pudendal artery and corpus cavernosum) defined by MRI: McLaughlin PW, Narayana V, Meirovitz A, Troyer S, Roberson PL, Gonda R Jr, Sandler H, Marsh L, Lawrence T, Kessler M, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI
    Journal Article

    Zelefsky, M.
    Urologic Oncology: Seminars and Original Investigations (2005)

    Fulltext@MSK | Save